SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a term loan agreement with Capital Royalty L.P. and certain of its affiliates. The agreement provides NanoString with up to $45 million of available borrowing capacity. “Together with the […]
BILLERICA, Mass. –– RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing. […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced new products that can be applied directly to the discovery and translation of genomic variation in blood and tissue associated with cancer. The expanded portfolio leverages the company’s industry-leading next-generation sequencing (NGS) and microarray scanning systems to deliver sample-to-data solutions for basic and clinical cancer research. New […]
SUNNYVALE, Calif. — Cepheid (NASDAQ: CPHD) today announced the release of Xpert® HPV, a 60-minute test for cervical cancer-related human papillomaviruses to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid’s GeneXpert® System, the world’s leading molecular diagnostic platform. Xpert HPV is […]
PALO ALTO, Calif. and LEXINGTON, Mass. — Syapse, the leading provider of software for bringing omics data into routine medical use, and N-of-One, the leading provider of clinical interpretation for precision medicine in oncology, today announced a partnership to make N-of-One’s clinical interpretation available to hospitals and laboratories through interfaces in the Syapse platform. This […]
Framingham – Early detection and treatment of inherited metabolic disorders in newborns can lessen the severity of health problems, which could cause mental and physical disabilities or death, if undetected. The window of opportunity to determine if a baby is at risk of a serious or life-threatening condition before symptoms begin is small; therefore, test […]
COLUMBIA, Md. – In response to a growing need for analytical measurement in healthcare applications, Shimadzu Corporation, Japan, has registered several of the company’s high-performance liquid chromatographs (HPLC) and high-performance liquid chromatograph mass spectrometers (LCMS) as Class I medical devices with the Food and Drug Administration. These are the first Shimadzu analytical instruments registered with […]
At the ACMG Annual Clinical Genetics meeting this week, Strand Life Sciences and Strand Genomics announced the release of the Avadis-NGS Server Edition, an enterprise solution to their widely adopted Next Generation Sequencing analytics platform. The Avadis-NGS Server Edition was designed to support the needs of multi-member teams and facilitates collaborative analysis through central storage […]
Framingham – Every organ transplant patient in the world faces the potential danger of his/her body rejecting a new organ, such as a heart, kidney or liver. Immunosuppressant drugs are required to help prevent rejection. To help improve the monitoring of this life-saving drug therapy, AB Sciex Pte. Ltd. today announced an immunosuppressants kit for […]
Salzburg, Austria, and Alameda, Calif., USA —– Sony DADC Austria AG and Singulex, Inc. today announced an exclusive multi-year supply agreement covering customized detection vessels designed and manufactured by Sony DADC BioSciences for the Sgx ClarityTM System, an ultrasensitive in vitro diagnostics (IVD) platform currently in development. Utilizing Singulex’s proprietary single molecule counting (SMCTM) technology, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
